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Abstract: Background: To assess the risk of aspiration, nutrient tolerance, and gastric emptying
of patients in ICUs, gastric ultrasound can provide information about the gastric contents. Using
established formulas, the gastric residual volume (GRV) can be calculated in a standardized way by
measuring the gastric antrum. The purpose of this study was to determine the GRV in a cohort of
enterally fed patients using a miniaturized ultrasound device to achieve knowledge about feasibility
and the GRV over time during the ICU stay. The findings could contribute to the optimization of en-
teral nutrition (EN) therapy. Methods: A total of 217 ultrasound examinations with 3 measurements
each (651 measurements in total) were performed twice daily (morning and evening) in a longitudinal
observational study on 18 patients with EN in the interdisciplinary surgical ICU of Saarland Univer-
sity Medical Center. The measured values of the GRV were analyzed in relation to the clinical course,
the nutrition, and other parameters. Results: Measurements could be performed without interrupting
the flow of clinical care and without pausing EN. The GRV was significantly larger with sparsely
auscultated bowel sounds than with normal and excited bowel sounds (p < 0.01). Furthermore, a
significantly larger GRV was present when using a high-caloric/low-protein nutritional product
compared to an isocaloric product (p = 0.02). The GRV at the morning and evening measurements
showed no circadian rhythm. When comparing the first and last ultrasound examination of each
patient, there was a tendency towards an increased GRV (p = 0.07). Conclusion: The GRV measured
by miniaturized ultrasound devices can provide important information about ICU patients without
restricting treatment procedures in the ICU. Measurements are possible while EN therapy is ongoing.
Further studies are needed to establish gastric ultrasound as a management tool in nutrition therapy.
Keywords: intensive care; gastric ultrasound; multi-organ point-of-care ultrasound (MOPOCUS);
critical illness; enteral nutrition
1. Introduction
Nutrition is essential for recovery and vitality as each body requires an individual
amount of carbohydrates, protein, fat, vitamins, and minerals for physiological function-
ing [1]. However, many patients are restricted in their dietary intake for various reasons.
This is relevant for critically ill patients in particular. In the context of intensive care treat-
ment, especially in cases of reduced nutritional intake and intestinal dysfunction, enteral
nutrition plays an important role [2]. In cases of existing or impending malnutrition, EN
can be administered by gravity drainage or active suctioning. Liquid nutrition can be
administered continuously or on an intermittent basis.
Early initiation of EN with adequate nutrient delivery improves clinical outcome and
is considered a proactive therapeutic strategy to reduce complications [2–4].
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Like any medical procedure, EN is associated with risks. A frequent complication is
regurgitation of gastric contents into the bronchial system. This can result in aspiration
pneumonia, which leads to acute respiratory failure in up to 30% of patients in ICUs and
death in 16% of cases [5].
GRV is taken to assess the risk of aspiration, nutrient tolerance, and gastric empty-
ing [6] of patients in ICUs. Several methods are available for this purpose. The reflux test
works by gravity drainage into a reservoir and is used in daily routine [7,8]. However, the
test is controversial due to standardization [7,9]. Therefore, the determination of the GRV in
the routine care of enterally fed intensive care patients is no longer generally recommended
since the current joint guidelines of the Society of Critical Care Medicine (SCCM) and the
American Society for Parenteral and Enteral Nutrition (ASPEN) [3].
Gastric-emptying disorders may occur frequently in patients requiring intensive
care [9]. Possible complications such as aspiration during nutrition therapy to critically ill
patients could be prevented by monitoring the GRV [10]. For this reason, there is a need
for a method that can reliably and practicably monitor GRV.
US devices are widely available in ICUs and offer a non-invasive way to determine
the GRV. The handling is familiar to most clinicians, and gastric sonography can be learned
with a manageable amount of time [11].
In this regard, gastric sonography can provide quantitative and qualitative information
about the gastric contents [12], and thus offers more advantages than the reflux test, which
only allows for a quantitative determination of the gastric contents.
In 2009, Perlas et al. established a formula for the standardized determination of GRV
by measuring the gastric antrum in patients in the right lateral decubitus position [13]. As
measurement in this position is not always possible in intensive care patients, a formula
was developed by Bouvet et al. in 2011 that allows for the determination of the GRV in the
supine position [14].
The measurements are also possible with miniaturized US devices, so-called “pocket
devices” [15,16]. Despite this, no studies have been performed on ultrasound-assisted
monitoring of GRV in the context of EN in a close-meshed longitudinal setting.
Therefore, the aim of this study was to determine the GRV in the longitudinal course
in critically ill patients using a pocket device in order to gain insight into how GRV behaves
over time during the ICU stay.
2. Materials and Methods
After obtaining local ethics committee approval (State Chamber of Physicians of
Saarland No. 57/19), all patients of the interdisciplinary surgical ICU of the Saarland
University Medical Center who were fed enterally during the study period from June to
December 2019 were evaluated for inclusion in the study. Exclusion criteria comprised
age younger than 18, preceding surgical gastrectomy, prone position, pregnancy, and
patients with abdominal vacuum therapy, if the wound sponge restricted the access to the
epigastrium necessary for the US investigation. Written informed consent was obtained
from all patients involved in the study or their legal representatives.
All patients were examined with the pocket device iViz (P20018-03, FUJIFILM Sonosite,
Inc., Bothell, WA, USA) with a touchscreen. For all examinations the convex transducer
model C60v (2–5 MHz, scan depth: 30 cm) was used and the standard setting “Abdomen”
without image optimization.
The measurements were started at the next possible date after written informed
consent. Patients were examined twice daily until the EN was terminated, relocated, or
until the patient’s death. Usually, the 1st measurement was performed in the morning
between 6:00 a.m. and 10:00 a.m., and the 2nd measurement in the afternoon/evening
between 4:00 p.m. and 8:00 p.m. without a passive reflux test in the period of 2 h before the
measurement. Occasionally, this period had to be deviated from or measurements had to
be omitted in order not to influence clinical procedures, e.g., due to operative interventions
or examinations. All examinations in this study were performed by the first author himself,
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so that variations in the measurements due to the examiner could be excluded. To obtain
comparable results, all measurements were performed in a supine position.
Prior to each ultrasound examination, the bowel sounds were auscultated and grouped
into three categories (sparse/normal/excited).
The average values were obtained from the three measurements per study, and the
cross-sectional area was calculated according to Perlas et al. [13] using AP and CC distances
and the GRV according to Bouvet et al. [14]. For better comparability, the volumes were
also calculated in mL/kg body weight (bw). The dependent two-sample t-test was used
to compare the study results. Two-sided p-values < 0.05 were regarded as significant.
Demographic data and data on hospitalization and health status were included. The
APACHE II, SAPS II, and SOFA scores were documented at patient admission and because
of the partial delay in starting enteral nutrition before the first measurement. Patient-related
data were collected from the hospital information system (i.s.h.med of SAP SE, Berlin,
Germany) and the patient data management system of the interdisciplinary operative ICU
(COPRA PDMS of COPRA System GmbH, Berlin, Germany). All data were anonymized.
3. Results
3.1. Patient Collective and Clinical History
The study included 18 critically ill patients who required intensive medical therapy
in the interdisciplinary surgical ICU. Patients were examined twice daily as long as the
medical indication for EN via nasogastric tube existed. A total of 217 examinations, and
thus 651 single measurements, were performed and evaluated. The demographics are
given in Table 1.
Table 1. Demographics.
Characteristics Frequency or Mean ± SD
Gender (Male) 15 (83.3%)
Age (years) 66.9 ± 10.4
Height (cm) 176 ± 8
Body weight (kg) 88 ± 15
BMI (kg/m2) 29 ± 4
Coronary heart disease 4 (22.2%)
Diabetes mellitus 2 2 (11.1%)
Stroke 5 (27.8%)
Trauma surgery 6 (33.3)
Abdominal surgery 7 (38.9%)
Other (surgery) 5 (27.8%)
The average length of stay of patients in the interdisciplinary surgical ICU was
29.0 ± 19.3 days; and three patients (16.7%) died during their stay.
Patients were mechanically ventilated in 48.4% of the examinations (n = 105). In
29 cases (13.4%), patients were treated with catecholamines on examination.
The summary of APACHE II, SAPS II, and SOFA data are given in Table 2.
Table 2. Scores of patient condition and clinical progress.
On Arrival (ICU) Before First Measurement
APACHE II 19.7 ± 3.3 16.4 ± 4.5
SAPS II 38.1 ± 7.5 32.2 ± 10.9
SOFA 4.8 ± 1.7 3.6 ± 2.9
APACHE II: Acute Physiology and Chronic Health Evaluation, SAPS II: Simplified Acute Physiology Score, SOFA:
Sequential Organ Failure Assessment Score.
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3.2. Nutrition
In total, 163 examinations (75.1%) took place during ongoing nutritional therapy. In
the remaining 54 examinations (24.9%), nutritional intake was interrupted during the
measurement. In addition to the standard preparations of Fresubin® original fibre and
Fresubin® energy fiber, the patients were fed with the products Fresubin® 2 kcal HP and
Fresubin® HP energy. The characteristics and frequency of use of the nutritional products
at the time of the study are shown in Table A1.
Furthermore, the pump rate of EN at the time of the examination, the average pump
rate, and the cumulative total amount of food supplied between the current and the last
US examination were calculated (see Table A2). The average time between measurements
was 13.8 ± 9.8 h.
In 1 case (0.5%), vomiting was documented in the time between two examinations; in
27 cases (12.4%), the patients took in oral food in addition to EN. In most cases (n = 25),
this involved liquid foods, and in two cases it involved solid foods.
3.3. Ultrasound Examinations
3.3.1. Feasibility of the Measurements
The first finding is that performance of the US examination was possible in all 217 cases
with three measurements each, irrespective of pre-existing diseases, the diet, or the condi-
tion of the patients or any clinical parameters. Additionally, no medical examinations or
nursing activities were delayed during this observational study. Moreover, the patients
did not have to be prepared for the measurements, for example by adjusting the EN, the
ventilation, or the medication.
3.3.2. Results of the Ultrasound Examinations
Figure 1 shows the measured GRV as a box plot.
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Figure 1. Measurement results of GRV, calculated according to Bouvet et al. (formula for measure-
ments in supine position) [14] in mL/kg bw.
The average CSA was 9.9 ± 3.6 cm2. The GRV was calculated to be 67.4 ± 21.3 mL or
0.73 ± 0.30 mL/kg bw.
In order to show the longitudinal course, the first US measurement of each patient
was compared with the last measurement of the study performed with regard to the GRV
in mL/kg bw. These results are shown in Figure 2.
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owel sounds. However, th GRV was significa tly increased in parse (0.99 ± 43) bowel
s unds compared to normal (p < 0.01) and excited bowel sounds (p < 0.01).
4. Discussion
To the best of our knowledge, this is the first study of ultrasound-assisted monitoring
of GRV during EN in a close on itudinal follow-up. The main findi g is that the onitori
of in ICU patie ts is feasible using pocket device. Neither EN nor clinical tr atment
p ocesses had to be interrupted in the process.
4.1. Assessment of GRV
The o it ring of GRV in ICU patients is no longer recommended in the current joint
low-evidence guidelines of SCCM and ASPEN [3]. The most important reason for this is
that EN must be interrupted to determine the GRV. Since EN is administered continuously
in most cases, a significant amount of infused nutritional product is missing due to the
interruption time [3,17].
However, the amount of nutrition administered is related directly to the prognosis of
the disease and the course of the ICU stay. If EN does not have to be stopped because of
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the routine monitoring of GRV, the daily prescribed nutrient requirement can be managed
better [17–19].
The significance of measuring GRV in ICUs is controversial. A clear significance to
reduce aspiration pneumonia has not been demonstrated in some studies [17,20–23], but a
lower incidence of vomiting with lower GRV has [20,24]. Therefore, in its 2019 guideline,
ESPEN considers it reasonable to continue to use GRV to detect intolerance to EN [10].
If the GRV threshold at which nutritional therapy is switched or discontinued or set too
low, the patient may receive too few nutrients even though there is no increased risk of
aspiration [25].
Consideration must therefore be given to whether interruption of EN justifies the
control of GRV. Furthermore, it has to be considered that, in the case of increased GRV, the
reduction or discontinuation of EN on the one hand represents a risk in terms of reduced
nutrient intake, but on the other hand also offers protection against vomiting.
Gastric ultrasound is a way to determine the GRV without having to interrupt EN,
as our study was able to show. Therefore, at least the failure of the infused food volume
during the examination can be avoided [26].
Thus, when checking the GRV with ultrasound, vomiting can be probably prevented
at the same time and nutrient intake can be better achieved.
4.2. Use of Pocket Devices
In comparison to standard US devices, pocket devices have a smaller size and weight,
may bring time savings [27], can be used more easily in the hospital setting, and are also
available for emergency medicine or home visits. These attributes could be confirmed in
our study, especially due to the small size of the device and the fast set-up and take-down,
the examinations could be well integrated into the clinical routine. The US examination
was possible in 100% of the cases. In particular, the patients did not have to be prepared
for the measurements. As a result, high clinical reproducibility can be assumed.
Gastric US with pocket devices has been presented in two studies to date. Kaydu
and Gokceket (2018) studied the GRV in 120 patients in relation to the duration of food
abstinence before anesthetic induction [16]. With increasing duration of food abstinence,
the CSA decreased significantly. Fasting or malnutrition is therefore also visible based on
the GRV using ultrasound. Skornik (2018) tested the feasibility of sonography-assisted
measurement of the GRV of enterally fed ICU patients with the pocket device V-Scan,
comparing the results with the standard device Vivid i9 (both GE Healthcare) and the
passive reflux test [15]. The measurement results with the pocket device correlated strongly
with those of the standard device and the positive passive reflux test. In this regard, the
results are comparable to current methods for monitoring GRV.
4.3. Measurement Results Analysis
4.3.1. GRV Compared to Bowel Sounds
When comparing auscultated bowel sounds with the measured GRV in this study,
the results were similar for normal and excited bowel sounds. In sparse bowel sounds,
however, the measured GRV seems significantly increased compared to normal and exited
bowel sounds.
Although auscultation of bowel sounds is considered an integral part of the clinical
examination, its diagnostic significance is widely unexplored [28]. Nevertheless, in some
cases, auscultation may provide evidence of pathology. In a review paper, Li et al. pre-
sented the relationships between bowel sounds and gastrointestinal motility in critically ill
patients [29].
However, there is no standard terminology for the classification of bowel sounds [30],
which limits comparability with other studies. Taken together, we believe that gastric
ultrasound could be a solution for an objectifiable assessment of GI motility through the
association with bowel sounds demonstrated in this study.
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4.3.2. GRV at Morning and Evening Measurements and at First and Last
Ultrasound Examination
When comparing the morning and evening examinations, the mean values of the
measurement results were approximately constant, so that no circadian variation of the
GRV was detected in this study.
In a physiological setting, the GI tract is subject to circadian rhythms that coordinate
peripheral organs and control, among other things, enzyme production, which adjusts the
body to alternating phases of food intake and fasting [31,32]. This can be severely affected
in critically ill patients [9,17,33].
Therefore, gastric ultrasound in ICUs may play an important role in future stud-
ies to improve our knowledge of the circadian rhythms of ICU patients with respect to
gastrointestinal function.
Furthermore, there was a tendency for the last measurement to indicate a larger GRV
than the initial measurement. A stay of at least 24 h in the ICU is associated with the
development of gastrointestinal dysfunction [34,35], as evidenced by, among other things,
decreased GI motility [36], which causes increased GRV [17]. The small number of patients
in this study as well as the different length of stay in the ICU might be the reason why no
significant results could be shown.
4.3.3. GRV by Using Different Nutritional Products
In our study, a total of four nutritional products were recorded. The measured GRVs
were similar for the products Fresubin® original fiber, Fresubin® 2 kcal HP, and Fresubin®
HP energy. Only in the case of the high-calorie product Fresubin® energy fiber were larger
volumes measured. In addition to a higher number of calories, this product also contains
less dietary fiber.
Additionally, other studies investigated the effects of different nutritional products
on the GI tract of ICU patients. Spindler-Vesel et al. showed a larger GRV in enterally
fed ICU patients on high-fiber standard diets than on low-fiber, high-calorie diets [37].
Chittawatanarat et al. also investigated the effects of dietary products on digestion [38]. In
contrast, Yagmurdur et al. found no significant differences in the GRV between cohorts on
high-fiber and low-fiber diets [39].
In conclusion, the study situation regarding the influence of different dietary products
on the GRV in ICU patients is controversial. Even major reviews do not reach a clear
conclusion [40,41], which might be related to the dynamics of the metabolism of critically
ill patients as well as the consequent non-constant energy demand [41]. It is necessary
to conduct further studies to make clear recommendations on nutrient intake for specific
patient groups.
4.4. Limitations
The patient population contained 83.3% (n = 15) male patients and 16.7% (n = 3)
female patients. The patient collective also had an inhomogeneous structure in terms of
duration of hospitalization, number and type of surgery, and medication. The aim of the
work was to show the longitudinal course of the patients who were fed enterally. For
this purpose, all enterally fed critically ill patients were included, with the exception of
the above-mentioned patient groups. Therefore, it was more important to represent a
cross-section of the patient collective of the local ICU than a homogeneous, selected patient
group for better reproducibility. Results must be interpreted carefully due to low patient
numbers. The individual examinations were not independent, as they were performed on
the same patient cohort. The possibilities for statistical analyses were therefore limited.
4.5. Conclusions
The GRV measured by miniaturized ultrasound can provide important information
about ICU patients without restricting treatment procedures in the ICU. The measure-
ments are possible during ongoing EN therapy. The examinations can be performed
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intuitively after brief training, and the procedure provides more extensive information
beyond auscultation and passive reflux testing.
In the future, gastric ultrasound could play an important role in planning enteral feed-
ing therapy. Adjustment of the pump rate would be possible under ultrasound guidance;
at the same time, complications such as aspiration could be reduced.
Further studies with higher patient numbers are needed to confirm the results of this
study and to establish gastric ultrasound in feeding therapy.
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Appendix A
Table A1. Characteristics [42] and use of nutritional products at the time of study.
Product: Fresubin® Contents Use at the Time of Examination
original fiber (isocaloric, with dietary
fiber, low protein)
Calories: 1.0 kcal/mL 32
(19.6%)Dietary fiber: 1.5 g/100 mLProtein: 3.8 g/100 mL
energy fiber (high caloric, with dietary
fiber, low protein)
Calories: 1.5 kcal/mL 48
(29.4%)Dietary fiber: 1.1 g/100 mLProtein: 3.8 g/100 mL
2 kcal HP (high caloric, without dietary
fiber, high in protein)
Calories: 2.0 kcal/mL 72
(44.2%)Dietary fiber: 0.0 g/100 mLProtein: 10.0 g/100 mL
HP energy (high caloric, without dietary
fiber, high in protein)
Calories: 1.5 kcal/mL 11
(6.7%)Dietary fiber: 0.0 g/100 mLProtein: 7.5 g/100 mL
Total 163(100.0%)
Table A2. Run rate of EN at the time of examination, average run rate since the last examination, and cumulative total since
the last examination.
Product: Fresubin® Run Rate at the Time ofExamination
Average Run Rate Since the
Last Examination
Cumulative Total Since the
Last Examination
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